% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • AccuGrowth AccuGrowth Jan 17, 2008 10:57 PM Flag

    AccuGrowth BUY Signal

    AccuGrowth bought more INSM shares today and has upgraded his sentiment to BUY.

    Investors who purchases in the $.60 to $.79 range and are willing to hold INSM shares for 2 or more years have a good chance of being rewarded versus the risk of any serious erosion in the stock price. The risk of delistment from the NASDAQ GM is basically priced in at this point.

    Today's volume indicated that there are investors out there willing to pick up shares of INSM on any weakness. INSM is due to report on several projects soon to include:

    ROP -results of P1 study from Harvard/Switzerland

    HARS -results are expected to be good

    ALS -Q4 income from Italy is expected to increase indicating additional patients winning court approval and the initiation of increased dosing is proceeding, plus IPLEX continues to be well tolerated

    MMD -Fall of 2008 with an earlier announcement that the study is fully subscribed anytime soon

    FOB -Management is expected to indicate that talks are still ongoing with a revised target of H2 of 2008

    Prostate Cancer -a positive study has been published in a professional journal but a news release has not been distributed yet

    SortNewest  |  Oldest  |  Most Replied Expand all replies
12.45+0.30(+2.47%)May 2 4:00 PMEDT